Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K
Bone Disorders01:29

Bone Disorders

4.2K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Circulating Lipidomic Biomarkers of Malnutrition Risk among Oncology Patients in the Total Cancer Care (TCC) Study: A Cross-Sectional Analysis.

The Journal of nutrition·2026
Same author

Allostatic Load, Multimorbidity, and Overall and Cancer-Specific Survival among Older Adults in the United States.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysis.

medRxiv : the preprint server for health sciences·2026
Same author

ShinyEvents: harmonizing longitudinal data for real-world survival estimation.

NPJ precision oncology·2026
Same author

Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations.

JAMA network open·2025
Same journal

A Case Report of Unanticipated Difficult Intubation Due to Posterior Tracheal Angulation.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

Factors Influencing Outcomes of a Telehealth-Based Physical Activity Program in Older Veterans Postdischarge.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

Updates in Multiple Sclerosis Imaging.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

Impact of Retroactive Application of Updated Surveillance Guidelines on Endoscopy Center Capacity at a Large VA Health Care System.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

The Integration of Extended Reality in Arthroplasty: Reviewing Technological Progress and Clinical Benefits.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

American Hunger Games: Food Insecurity Among the Military and Veterans.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
See all related articles

Related Experiment Video

Updated: Oct 14, 2025

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.7K

Bone Health in Patients With Prostate Cancer: An Evidence-Based Algorithm.

Eric D Johnson1, Katerina Butler1, Sumati Gupta1

  • 1and are Oncologists, and is a Clinical Oncology Pharmacist; all at George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, Utah. Eric Johnson is a Clinical Fellow and Sumati Gupta is an Assistant Professor, both at Huntsman Cancer Institute at the University of Utah in Salt Lake City.

Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|November 4, 2021
PubMed
Summary
This summary is machine-generated.

Androgen deprivation therapy (ADT) for prostate cancer can cause bone loss and fractures. Bone-modifying agents are recommended to mitigate these risks and improve patient outcomes.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

85.4K

Related Experiment Videos

Last Updated: Oct 14, 2025

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.7K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

85.4K

Area of Science:

  • Oncology
  • Geriatrics
  • Bone Metabolism

Background:

  • Prostate cancer affects a significant portion of the veteran population.
  • Long-term androgen deprivation therapy (ADT) is a standard treatment for advanced prostate cancer.
  • Survivorship and treatment complications are key concerns in prostate cancer care.

Purpose of the Study:

  • To review current research on bone health in men undergoing prostate cancer treatment.
  • To present an evidence-based approach for managing bone health complications.
  • To provide guidance on monitoring and interventions for bone health during ADT.

Main Methods:

  • Literature review of recent studies on prostate cancer and bone health.
  • Development of a clinical algorithm for bone health management.
  • Analysis of treatment outcomes and risk factors for bone complications.

Main Results:

  • Prolonged ADT is associated with significant bone loss and increased fracture risk.
  • Bone-modifying agents (bisphosphonates, RANKL inhibitors) reduce fracture risk.
  • These agents are crucial for both hormone-naive and castration-resistant prostate cancer patients with bone involvement.

Conclusions:

  • Bone health complications are a critical consideration in long-term prostate cancer management.
  • An evidence-based algorithm can guide monitoring and intervention strategies.
  • Proactive bone health management improves survivorship and reduces mortality in prostate cancer patients.